Western Standard LLC, Director at MERRIMACK PHARMACEUTICALS INC (MACK), bought 61,264 shares at $11.33 ($694K) on 2023-01-03, disclosed to the SEC on 2023-01-04.
Open-market purchase of $694k MACK by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.33 | 8,219 | $93K | 13.4% |
| 2 | $11.33 | 8,219 | $93K | 13.4% |
| 3 | $11.33 | 22,413 | $254K | 36.6% |
| 4 | $11.33 | 22,413 | $254K | 36.6% |
| Total | $11.33 avg | 61,264 | $694K | 100% |
| Filing → |
| MACK | BUY | 2023-03-01 | $363K | — | Filing → |
| MACK | BUY | 2023-01-03 | $5.5M | — | Filing → |
| MACK | BUY | 2020-11-27 | $504K | — | Filing → |